| Previous close | 10.89 |
| Open | 10.75 |
| Bid | 0.00 |
| Ask | 0.00 |
| Strike | 105.00 |
| Expiry date | 2024-01-19 |
| Day's range | 10.75 - 10.89 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
- Simply Wall St.
44%of this Moderna, Inc. (NASDAQ:MRNA) insider's holdings were sold in the last year
Looking at Moderna, Inc.'s ( NASDAQ:MRNA ) insider transactions over the last year, we can see that insiders were net...
- Motley Fool
Moderna Stock: Buy, Sell, or Hold in 2023?
Moderna (NASDAQ: MRNA) shares delivered top returns to investors in the earlier days of the pandemic. This year, though, the stock is heading for a 30% loss, even though Moderna's coronavirus vaccine generates billions in revenue and profit. Looking ahead to 2023, you might be wondering whether Moderna's best days are in the past -- or if this vaccine maker still presents an opportunity.
- Zacks
Novavax (NVAX) Stock Nosedives 88% This Year: Here's Why
Novavax (NVAX) drops to record lows as the delayed product launch of its COVID-19 vaccine made it lose market share. Management slashes revenue guidance by more than half.
© 2022 Yahoo. All rights reserved.
